ZHANG Yiming,WANG Zijian,TIAN Xinchen,et al.Pathomechanism and Treatment Strategy of Phlegm and Blood Stasis in the Immunosuppressive Tumor Microenvironment of Liver Cancer[J].Journal of Traditional Chinese Medicine,2025,66(14):1444-1449.
ZHANG Yiming,WANG Zijian,TIAN Xinchen,et al.Pathomechanism and Treatment Strategy of Phlegm and Blood Stasis in the Immunosuppressive Tumor Microenvironment of Liver Cancer[J].Journal of Traditional Chinese Medicine,2025,66(14):1444-1449.DOI: 10.13288/j.11-2166/r.2025.14.007.
Pathomechanism and Treatment Strategy of Phlegm and Blood Stasis in the Immunosuppressive Tumor Microenvironment of Liver Cancer
LIU J , CHEN Z , LI Y , et al . PD-1/PD-L1 checkpoint inhibitors in tumor immunotherapy [J]. Front Pharmacol , 2021 , 12 : 731798 . doi: 10.3389/fphar.2021.731798 http://dx.doi.org/10.3389/fphar.2021.731798 .
OURA K , MORISHITA A , TANI J , et al . Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review [J]. Int J Mol Sci , 2021 , 22 ( 11 ): 5801 .
SHEN KY , ZHU Y , XIE SZ , et al . Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives [J]. J Hematol Oncol , 2024 , 17 ( 1 ): 25 .
YANG L , LI A , LEI Q , et al . Tumor-intrinsic signaling pathways: key roles in the regulation of the immuno-suppressive tumor microenvironment [J]. J Hematol Oncol , 2019 , 12 ( 1 ): 125 .
GALASSI C , CHAN TA , VITALE I , et al . The hallmarks of cancer immune evasion [J]. Cancer Cell , 2024 , 42 ( 11 ): 1825 - 1863 .
HILMI M , NEUZILLET C , CALDERARO J , et al . Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions [J]. J Immunother Cancer , 2019 , 7 ( 1 ): 333 .
CHEN C , WANG Z , DING Y , et al . Tumor micro-environment-mediated immune evasion in hepatocellular carcinoma [J]. Front Immunol , 2023 , 14 : 1133308 . doi: 10.3389/fimmu.2023.1133308 http://dx.doi.org/10.3389/fimmu.2023.1133308 .
BOEDTKJER E , PEDERSEN SF . The acidic tumor microenvironment as a driver of cancer [J]. Annu Rev Physiol , 2020 , 82 : 103 - 126 . doi: 10.1146/annurev-physiol-021119-034627 http://dx.doi.org/10.1146/annurev-physiol-021119-034627 .
DONNE R , LUJAMBIO A . The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma [J]. Hepatology , 2023 , 77 ( 5 ): 1773 - 1796 .
TIAN X , LIU F , WANG Z , et al . Modified Biejia Jianwan decoction restrains PD-L1-mediated immune evasion through the HIF-1α/STAT3/NF-κB signaling pathway [J]. J Ethnopharmacol , 2024 , 322 : 117577 . doi: 10. 1016/j.jep.2023.117577 http://dx.doi.org/10.1016/j.jep.2023.117577 .
XUE R , ZHANG Q , CAO Q , et al . Liver tumour immune microenvironment subtypes and neutrophil heterogeneity [J]. Nature , 2022 , 612 ( 7938 ): 141 - 147 .
JOB S , RAPOUD D , DOS SANTOS A , et al . Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma [J]. Hepatology , 2020 , 72 ( 3 ): 965 - 981 .
Discussion on Pathogenesis and Treatment of Esophageal Precancerous Lesions from the Perspective of "Turbidity Damaging the Clear and Harmonious"
HU Kaiwen's Experience in Treating Lung Cancer by Regulating Tumor Microenvironment Based on the Theory of "One Qi Circulation,Earth as Pivot to Circulate and Transform Four Elements"
Correlation Between "Pathological Accumulation from Collateral Obstruction" and Gap Junction Communication Dysfunction and Its Application in Tumor Prevention and Treatment
Effect of Shipi Xiaoji Beverage(实脾消积饮)-containing Serum on Mitochondrial Dynamics Imbalance and Ferroptosis of Liver Cancer HepG2 Cells
The Effects of Huqi Zhengxiao Formula (槲芪癥消方) on the Survival Rate and Quality of Life of Patients of Stage Ⅲ Hepatitis B-Associated Primary Liver Cancer with Syndrome of Healthy Qi Deficiency, Toxic Stasis Accumulation After Transcatheter Arterial Chemoembolisation Treatment
Related Author
HE Cong
XU Tingting
WANG Yi
KONG Jing
WANG Xiao
WANG Xiaosu
FAN Shumiao
ZHU Shengliang
Related Institution
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine
Xiyuan Hospital,China Academy of Chinese Medical Sciences
Dongfang Hospital,Beijing University of Chinese Medicine
Heilongjiang Academy of Chinese Medicine
Guang 'anmen Hospital,China Academy of Chinese Medical Sciences